Featured Articles

  1. Cytiva Opens Cell Culture Center Of Excellence In Massachusetts 11/9/2022

    Global life sciences leader Cytiva opened a new Cell Culture Center of Excellence at its Marlborough, Massachusetts location.

  2. 5 Translational Research Challenges On The Path To Patients 10/19/2022

    As a translational researcher, you’re paving an uncharted path toward exciting new possibilities in healthcare. Explore five difficulties translational researchers face when developing a new therapy.

  3. Investments, Capacity Expansion, And Improvements 10/7/2022

    An ongoing strategic growth plan is expanding our manufacturing capacity and services across geographies so we are able to better meet increased demand and have improved lead times for key products.

  4. Cytiva Strengthens Cell Line Development With CEVEC Acquisition 10/6/2022

    Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing technologies. CEVEC will further strengthen Cytiva's leading position in biomanufacturing solutions.

  5. Dry Powdered Medium Milling Equivalency Study 9/26/2022

    An assessment of the physical, chemical, and biological characteristics of representative complex media and feeds was made to compare pin mills and overall dry powdered medium manufacturing processes.

  6. Origin Equivalence Study: HyClone Characterized Fetal Bovine Serum (FBS) 9/26/2022

    Evaluate the cell culture and production performance of a fetal bovine serum brand with samples originating in three different countries, using three separate lots per country.

  7. From Discovery To Commercial Promise With Philogen's Dr. Dario Neri 9/23/2022

    In a recent episode of The Business of Biotech, Philogen CEO Dr. Dario Neri sat down to explore his journey from academia to startups, as well as Philogen's own trajectory.

  8. Rethinking Cancer Treatment With Anixa's Amit Kumar 8/18/2022

    Overcoming the hurdles of CAR-T therapy development for solid tumors will require novel science, innovative processing, and unshakeable optimism.

  9. Gene Therapies For Better Kidney Treatments With Purespring Therapeutics 8/16/2022

    Purespring Therapeutics explores the importance of pursuing new treatments for kidney conditions and shares why it's poised for long-range commercial success.

  10. Pursuing Growth Strategies And Aggressive Advocacy 8/10/2022

    Review what the President and CEO of a clinical-stage genomic medicines company had to say about growth strategy and his progress in the pursuit of gene therapies to address inherited retinal diseases.